Mitochondrial Targeted Therapies to Prevent Maternal Diabetes-Induced Congenital Heart Defects

JACC Basic Transl Sci. 2024 Mar 28;9(3):319-321. doi: 10.1016/j.jacbts.2024.01.016. eCollection 2024 Mar.

Author

Affiliation

¹ Department of Pediatrics (Cardiology) and Cardiovascular Institute, Stanford University, Stanford, Califiornia, USA.

No abstract available

Keywords: congenital heart defects; fusion; maternal diabetes; mitochondria.

Publication types

Editorial

Grants and funding

R01 HL165245/HL/NHLBI NIH HHS/United States